APC and neoplasm: Moreover, genetic alterations of β-catenin and inactivating mutations on adenomatous polyposis coli (APC) result in an aberrant nuclear/cytoplasmic expression of β-catenin in the morular component of the neoplasm due to decreased β-catenin degradation.